Market Tracker

09/23 5:16pm ET

Endocyte Inc (NASDAQ:ECYT)

3.13
Delayed Data
As of Sep 23
 -0.01 / -0.32%
Today’s Change
2.65
Today|||52-Week Range
5.63
-21.95%
Year-to-Date
Subscriber Comment of the Week
Sep 21 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close3.14
Today’s open3.11
Day’s range3.04 - 3.17
Volume118,295
Average volume (3 months)136,554
Market cap$132.3M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-14.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.77

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...+0.05+1.59%
MDGLMadrigal Pharmaceuti...+0.09+0.78%
CORICorium International...0.000.00%
NVLSNivalis Therapeutics...-0.28-3.23%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts